Logo image of LIZI

LIZHI INC (LIZI) Stock Fundamental Analysis

USA - NASDAQ:LIZI - US53933L2034 - ADR

2.8 USD
+0.06 (+2.19%)
Last: 1/24/2024, 8:00:03 PM
2.89 USD
+0.09 (+3.21%)
After Hours: 1/24/2024, 8:00:03 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LIZI. LIZI was compared to 80 industry peers in the Entertainment industry. LIZI has an average financial health and profitability rating. LIZI is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make LIZI a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year LIZI was profitable.
In the past 5 years LIZI reported 4 times negative net income.
In multiple years LIZI reported negative operating cash flow during the last 5 years.
LIZI Yearly Net Income VS EBIT VS OCF VS FCFLIZI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 -200M -400M -600M -800M -1B

1.2 Ratios

The Return On Assets of LIZI (14.87%) is better than 97.26% of its industry peers.
LIZI's Return On Equity of 23.66% is amongst the best of the industry. LIZI outperforms 93.15% of its industry peers.
The Return On Invested Capital of LIZI (14.23%) is better than 93.15% of its industry peers.
Industry RankSector Rank
ROA 14.87%
ROE 23.66%
ROIC 14.23%
ROA(3y)-19.87%
ROA(5y)-183.51%
ROE(3y)-55.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIZI Yearly ROA, ROE, ROICLIZI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 500 -500 1K 1.5K 2K

1.3 Margins

LIZI's Profit Margin of 4.79% is amongst the best of the industry. LIZI outperforms 80.82% of its industry peers.
LIZI's Operating Margin of 3.72% is fine compared to the rest of the industry. LIZI outperforms 65.75% of its industry peers.
LIZI has a Gross Margin (31.28%) which is in line with its industry peers.
In the last couple of years the Gross Margin of LIZI has grown nicely.
Industry RankSector Rank
OM 3.72%
PM (TTM) 4.79%
GM 31.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.69%
GM growth 5Y3.91%
LIZI Yearly Profit, Operating, Gross MarginsLIZI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 20 -20 -40 -60 -80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LIZI is creating value.
LIZI has more shares outstanding than it did 1 year ago.
The debt/assets ratio for LIZI has been reduced compared to a year ago.
LIZI Yearly Shares OutstandingLIZI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
LIZI Yearly Total Debt VS Total AssetsLIZI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

LIZI has an Altman-Z score of 0.35. This is a bad value and indicates that LIZI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.35, LIZI perfoms like the industry average, outperforming 46.58% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that LIZI is not too dependend on debt financing.
LIZI has a Debt to Equity ratio of 0.01. This is in the better half of the industry: LIZI outperforms 78.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACC1.94
WACC7.35%
LIZI Yearly LT Debt VS Equity VS FCFLIZI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.58 indicates that LIZI has no problem at all paying its short term obligations.
LIZI has a better Current ratio (2.58) than 80.82% of its industry peers.
LIZI has a Quick Ratio of 2.58. This indicates that LIZI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of LIZI (2.58) is better than 80.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.58
LIZI Yearly Current Assets VS Current LiabilitesLIZI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 200M 400M 600M

7

3. Growth

3.1 Past

LIZI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1683.33%, which is quite impressive.
Looking at the last year, LIZI shows a quite strong growth in Revenue. The Revenue has grown by 13.31% in the last year.
LIZI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.96% yearly.
EPS 1Y (TTM)1683.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)13.31%
Revenue growth 3Y22.78%
Revenue growth 5Y36.96%
Sales Q2Q%14.97%

3.2 Future

The Earnings Per Share is expected to decrease by -48.05% on average over the next years. This is quite bad
LIZI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 114.98% yearly.
EPS Next Y-96.37%
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%
EPS Next 5YN/A
Revenue Next Year747.7%
Revenue Next 2Y209.26%
Revenue Next 3Y114.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIZI Yearly Revenue VS EstimatesLIZI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
LIZI Yearly EPS VS EstimatesLIZI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.92 indicates a rather cheap valuation of LIZI.
Based on the Price/Earnings ratio, LIZI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.38. LIZI is valued rather cheaply when compared to this.
LIZI is valuated reasonably with a Price/Forward Earnings ratio of 10.34.
Based on the Price/Forward Earnings ratio, LIZI is valued cheaply inside the industry as 89.04% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of LIZI to the average of the S&P500 Index (22.86), we can say LIZI is valued rather cheaply.
Industry RankSector Rank
PE 0.92
Fwd PE 10.34
LIZI Price Earnings VS Forward Price EarningsLIZI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -5.38
LIZI Per share dataLIZI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

LIZI's earnings are expected to decrease with -48.05% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%

0

5. Dividend

5.1 Amount

LIZI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIZHI INC

NASDAQ:LIZI (1/24/2024, 8:00:03 PM)

After market: 2.89 +0.09 (+3.21%)

2.8

+0.06 (+2.19%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-14 2023-11-14/bmo
Earnings (Next)03-14 2024-03-14/amc
Inst Owners1.35%
Inst Owner Change-40.01%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.82M
Analysts85.71
Price Target1.43 (-48.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.92
Fwd PE 10.34
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.22
EV/EBITDA -5.38
EPS(TTM)3.04
EY108.57%
EPS(NY)0.27
Fwd EY9.67%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS62.58
BVpS12.66
TBVpS12.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.87%
ROE 23.66%
ROCE 18.29%
ROIC 14.23%
ROICexc N/A
ROICexgc N/A
OM 3.72%
PM (TTM) 4.79%
GM 31.28%
FCFM N/A
ROA(3y)-19.87%
ROA(5y)-183.51%
ROE(3y)-55.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.69%
GM growth 5Y3.91%
F-ScoreN/A
Asset Turnover3.11
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.07
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.58
Altman-Z 0.35
F-ScoreN/A
WACC7.35%
ROIC/WACC1.94
Cap/Depr(3y)93.44%
Cap/Depr(5y)138.6%
Cap/Sales(3y)1.02%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1683.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-96.37%
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%
EPS Next 5YN/A
Revenue 1Y (TTM)13.31%
Revenue growth 3Y22.78%
Revenue growth 5Y36.96%
Sales Q2Q%14.97%
Revenue Next Year747.7%
Revenue Next 2Y209.26%
Revenue Next 3Y114.98%
Revenue Next 5YN/A
EBIT growth 1Y1575%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-82.2%
EBIT Next 3Y15.08%
EBIT Next 5YN/A
FCF growth 1Y303.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y437.38%
OCF growth 3YN/A
OCF growth 5YN/A